3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition

InvestorPlace04-11

Wall Street often ignores stocks with tremendous potential. Esai (ESAIY): The Street is ignoring Eisai’s blockbuster Alzheimer’s treatment. Entain (GMVHY): Entain could become a takeover target ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2426308952?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-11 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2426308952","market":"us","top_or_hot":-1,"title":"3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition","media":"InvestorPlace","content":"<div>\n<p>Wall Street often ignores stocks with tremendous potential.\nEsai (ESAIY): The Street is ignoring Eisai’s blockbuster Alzheimer’s treatment. \nEntain (GMVHY): Entain could become a takeover target ...</p>\n\n<a href=\"https://investorplace.com/2024/04/3-stocks-wall-street-is-ignoring-but-you-shouldnt-april-edition/\">Source Link</a>\n\n</div>\n","source":"investorplace_stock_picks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-11 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2024/04/3-stocks-wall-street-is-ignoring-but-you-shouldnt-april-edition/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street often ignores stocks with tremendous potential.\nEsai (ESAIY): The Street is ignoring Eisai’s blockbuster Alzheimer’s treatment. \nEntain (GMVHY): Entain could become a takeover target ...</p>\n\n<a href=\"https://investorplace.com/2024/04/3-stocks-wall-street-is-ignoring-but-you-shouldnt-april-edition/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0109391861.USD","symbol_name":"富兰克林美国机遇基金A Acc","start_time":0,"source_url":"https://investorplace.com/2024/04/3-stocks-wall-street-is-ignoring-but-you-shouldnt-april-edition/","article_id":"2426308952","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2426308952","pubTimestamp":1712833200,"sourceInfo":{"source_id":"investorplace_stock_picks","name":"InvestorPlace stock picks"},"weMediaInfo":null,"summary":"Wall Street often ignores the stocks of companies with huge potential. Here are three overlooked stocks to buy.","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0109391861.USD":"富兰克林美国机遇基金A Acc","QLD":"纳指两倍做多ETF","LU0238689110.USD":"贝莱德环球动力股票基金","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","NVDA":"英伟达","LU0072462426.USD":"贝莱德全球配置 A2","PSQ":"纳指反向ETF","BIIB":"渤健公司","LU0312595415.SGD":"Schroder ISF Global Climate Change Equity A Acc SGD","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","GOTU":"高途","AMZN":"亚马逊","GMVHY":"ENTAIN PLC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","SQQQ":"纳指三倍做空ETF","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK4535":"淡马锡持仓","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","ESAIY":"Eisai Co., Ltd.","MGM":"美高梅","BK4527":"明星科技股","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","AAPL":"苹果","BK4552":"Archegos爆仓风波概念","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE00BD6J9T35.USD":"NEUBERGER BERMAN NEXT GENERATION MOBILITY \"A\" (USD) ACC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","BK4551":"寇图资本持仓","QID":"纳指两倍做空ETF","IE00BFSS8Q28.SGD":"Janus Henderson Balanced A Inc SGD-H","STEM":"Stem Inc.","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","BK4510":"在线教育","LU0149725797.USD":"汇丰美国股市经济规模基金","BK4548":"巴美列捷福持仓","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","IE00BJTD4N35.SGD":"Neuberger Berman US Long Short Equity A1  Acc SGD-H","LU0289941410.SGD":"AB FCP I Dynamic Diversified AX SGD","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","TQQQ":"纳指三倍做多ETF"},"translate_title":"华尔街忽略了3只股票（但你不应该）：4月版","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAPL":1,"AMZN":1,"BIIB":1,"STEM":1,"GMVHY":1,"NVDA":1,"MGM":1,"ESAIY":1,".IXIC":0.8,"TQQQ":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"NQmain":0.6,"MNQmain":0.6,"GOTU":0.6},"content_text":"Wall Street often ignores stocks with tremendous potential.\nEsai (ESAIY): The Street is ignoring Eisai’s blockbuster Alzheimer’s treatment. \nEntain (GMVHY): Entain could become a takeover target itself. \nStem (STEM): Stem is poised to benefit from increases in the utilization of electricity.\n\n\n\n\n\n \n\nSource: Shutterstock\n\n\n\nIf you think about it, many of today’s high-flying stocks were once ignored by the Street. Nvidia (NASDAQ:NVDA) was a struggling video-game chip maker, Amazon (NASDAQ:AMZN) was a fledgling online book seller and Apple (NASDAQ:AAPL) was a formerly successful PC maker, fighting to stay in business. Indeed, the Street tends to shun stocks with great potential that are not yet delivering huge revenue gains or impressive partnerships. Therefore, it’s certainly worthwhile for long-term investors to consider buying stocks that are largely being shunned by the most popular business-news pundits and the largest investors. Here are three such overlooked stocks to buy. \nEisai (ESAIY)\nSource: Sisacorn / Shutterstock.comThe Street is still not enthusiastic about Japanese drug maker Eisai (OTCMKTS:ESAIY), co-owner of the first-ever Alzheimer’s treatment, Leqembi, that has shown a significant amount of effectiveness. \nAccording to data reported late last year, 60% of a small group of early-stage Alzheimer’s patients who received the drug meaningfully improved. Among a larger group of patients with varied stages of the disease, cognitive decline was slowed by 27%. \nFor a variety of logistics-related reasons, the uptake of the drug has been slower than expected. Neurologists have been unenthusiastic about the treatment. Insurers’ reluctance and IV-only delivery likely explains physicians’ reticence. \nThankfully, Eisai has begun seeking FDA approval for a subcutaneous version of Leqembi which should ease the drug’s administration. Additionally, Eisai’s U.S. partner, Biogen (NASDAQ:BIIB), is reportedly working to increase insurance coverage of the treatment.\nIn spite of the problems, Eisai predicts that the drug will generate almost $2 billion in sales by fiscal year 2027 and $8 billion in revenue in fiscal year 2031. \nEntain (GMVHY)\nSource: Motortion Films / Shutterstock.comEntain (OTCMKTS:GMVHY), a UK-based online betting giant, delivered strong financial results in 2023. It also may greatly benefit from selling a stake in a joint venture to MGM (NYSE:MGM) and could itself become a takeover target.\nLast year, Entain’s revenue climbed 11% to 4.77 billion British pounds, while its operating profit, excluding certain items, jumped 18% to 641.8 million British pounds.\nMeanwhile, Entain and MGM’s joint venture, BetMGM, rose 36% last year, and the joint venture generated positive EBITDA in the second half of the year. BetMGM’s revenue and EBITDA are likely to climb tremendously as the platform expands to more states and as the popularity of online betting spreads in the U.S. \nThere have been rumors that MGM would look to buy Entain’s stake in BetMGM. If that does occur, Entain would likely have several billion dollars of cash that it could return to shareholders or use to acquire a profitable firm. \nFurther, the London Times recently reported that private equity firms are interested in buying Entain. If that occurs, of course, the company’s shares would soar. \nAll of Entain’s positive catalysts make it one of the best  overlooked stocks to buy.\nStem (STEM)\nSource: whiteMocca / Shutterstock.comStem’s (NYSE:STEM) AI-powered software maximizes the efficiency of electricity use. The electrification of transportation and the rapid proliferation of AI should cause Stem’s software demand to surge going forward. \nStem recently launched PowerBidder Pro to help energy traders and asset owners optimize their asset bids and manage risk. It also enables them, using AI, to predict their energy usage. The product appears to be geared to the owners of energy storage batteries, a sector that’s rapidly growing in America. \nEncouragingly, Stem already obtained a major customer and leading independent energy and commodity group, Mercuria, for PowerBidder Pro. Mercuria’s decision to purchase the product so soon after its launch bodes well for its outlook.\nStem expects to generate $50 million of cash this year, making it a prime choice among overlooked stocks to buy.\nOn the date of publication, Larry Ramer held long positions in STEM, ESAIY and MGM. His wife held a long position in BIIB. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.\nLarry Ramer has conducted research and written articles on U.S. stocks for 15 years. He has been employed by The Fly and Israel’s largest business newspaper, Globes. Larry began writing columns for InvestorPlace in 2015. Among his highly successful, contrarian picks have been SMCI, INTC, and MGM. You can reach him on Stocktwits at @larryramer.Artificial Intelligence, Biotech, Casino, Healthcare, Technology, Consumer Discretionary, TravelUndervalued Stocks\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSubmit\n\n\n\n\n\n\n\nArticle printed from InvestorPlace Media, https://investorplace.com/2024/04/3-stocks-wall-street-is-ignoring-but-you-shouldnt-april-edition/.\n©2024 InvestorPlace Media, LLC","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2426308952"}